Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2004-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22932639aa504afebb70d17cc5bdf1b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b88ada7c79789b3e454af5d3348c16db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa407a0e1729e48539a634ba9e4bdf4 |
publicationDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005118262-A1 |
titleOfInvention |
Controlled release formulation |
abstract |
The present invention discloses a controlled release formulation suitable for oral administration comprising N 6 -cyclopentyl-5′-(N-ethyl)carboxamidoadenosine or a pharmaceutically acceptable salt or ester thereof incorporated in a controlled release matrix. The controlled release formulation of the invention is especially suitable for treating heart rhythm disturbances in a mammal. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108445134-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012171733-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932554-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018142197-A1 |
priorityDate |
2003-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |